A high cannabinoid CB(1) receptor immunoreactivity is associated with disease severity and outcome in prostate cancer (Q82836893)

From Wikidata
Jump to navigation Jump to search
scientific article published on 04 December 2008
edit
Language Label Description Also known as
English
A high cannabinoid CB(1) receptor immunoreactivity is associated with disease severity and outcome in prostate cancer
scientific article published on 04 December 2008

    Statements

    A high cannabinoid CB(1) receptor immunoreactivity is associated with disease severity and outcome in prostate cancer (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit